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Summary: We evaluated bias and inaccuracy of four frequently used routine test systems for serum total calcium,
using a candidate reference method based on ion chromatography. The mean biases and 95% confidence intervals
that we observed were 0.0 ± 0.59% for Johnson & Johnson arsenazo(III), 1.3 ± 0.62% for Beckman arsenazo(III),
—0.4 ± 0.44% for Beckman applying ion selective electrode measurement after sample dilution, and
— 1.9% ± 0.42% for Boehringer o-cresolphthalein. The inaccuracy of all test systems was usually < 4.7% (calcu-
lated as deviation of singlicates from ion chromatography). Both bias and inaccuracy are discussed in the light of
specifications set by expert groups or derived from the biological variation of serum total calcium. The study
revealed that the intrinsic quality of commonly used test systems for serum total calcium satisfies even some of
the more stringent criteria for method bias and inaccuracy.
Introduction
Measurement of serum total calcium is still considered
a challenge for the routine laboratory, in particular
when analytical specifications are applied that have
been derived from the biological variation of the ana-
lyte (1). We therefore investigated the state-of-the-art
of the accuracy and specificity of routine serum total
calcium measurements. Four frequently used routine
test systems for serum total calcium were evaluated,
using a recently developed candidate reference method
based on ion chromatography (2, 3), applying split
sample measurement of a panel of patient samples.
The main emphasis of the study was assessment of
the overall bias of the test systems and their sensitivity
to common sample matrices. Quality control sera often
exhibit matrix effects (4, 5) and are hence not always
representative for the real test system performance.
Therefore quality control materials were not included
in the study.
Here, we present the observed deviations of the routine
test systems from the reference method, applying dif-
ferent specifications for analytical bias and inaccuracy
(6-10).
Materials and Methods
Operation of the routine test systems was the responsibility of the
respective manufacturers or distributors. The following methods
were investigated:
(i) the arsenazo-IH method from Johnson & Johnson Clinical Diag-
nostics (Rochester, NY, USA), performed in the Johnson & John-
son application laboratory at Illkirch (France) on a Vitros 250 ana-
lyzer;
(ii) the arsenazo-III method and
(iii) the indirect ion selective electrode (ISE) method from Beck-
man Instruments (Brea, CA, USA), performed at the site of the
Belgian distributor Analis (Namur, Belgium) on a Synchron CX4
and a CX3 Delta analyzer, respectively; and
(iv) the o-cresolphthalein method from Boehringer Mannheim
(Tutzing, Germany), performed in their application laboratory on a
Hitachi 717 analyzer.
The patient panel used for the study was kindly provided by
the Hospital "Institut Moderne" of Gent (Belgium). The samples
were treated in accordance with the ethical standards of the
Committee for Medical Ethics of the University of Gent. The
panel consisted of 88 randomly collected samples. All had been
ordered by physicians for total calcium analysis. They were
stored at —80 °C before their shipment in dry ice to the respec-
tive application laboratories. Because of the focus of our study
on test system calibration and behaviour with common samples,
no efforts were made to collect samples with calcium concentra-
tions far beyond the reference limits or samples that might
contain specific interferences.
Measurements by the routine systems were performed in triplicate
within one run and under rigorous internal quality control. Each
manufacturer used his own internal quality control samples. They
were placed at the beginning of the run (n = 9), each tenth sample
(n = 3), and at the end (n = 9).
The number of results reported back to us were 88 for Boehringer
and Beckman indirect ISE, 82 for Johnson & Johnson, and 59 for
Beckman arsenazo. The reduced number in the latter case was due
to limited sample volume. Measurements by ion chromatography
(2, 3) were performed in batches of 9—10 samples over a period
of 9 days. This measurement scheme was necessary because of the
relatively long Chromatographie runs. Also the ion chromatography
measurements were performed in triplicate, but each aliquot was
independently prepared. The internal quality control samples for
ion chromatography were the certified reference materials (CRMs)
303 and 304 from the Bureau Communautaire de Reference (BCR,
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Brussels, Belgium). They were measured at the start, hi the middle
and at the end of each run.
Results and Discussion
Internal quality control
In order to obtain results that were representative for the
respective test systems, the whole study was performed
in the application laboratories of the respective manufac-
turers or distributors under strict internal quality control,
measuring at least two control samples in blocks at the
start, in the middle and at the end of each run. The inac-
curacy limit of the mean of the internal quality control
measurements for each of the control samples was set at
1.5%. The respective target values were method-depen-
dent assigned values for both Beckman systems, and ref-
erence method values for the Boehringer test system.
Johnson & Johnson uses target ranges determined by
measurement of their control samples by numerous
laboratories using their routine kit. We used the mean of
this range as the target value.
The following mean deviations from the respective
target values were found: Johnson & Johnson -2.2%
(at 2.30 mmol/1) and 0.8% (at 2.90 mmol/1); Beckman
arsenazo/indirect ISE 0.3%/-0.6% (at 2.28/2.33
mmol/1), -0.4%/-1.0% (at 2.83/2.85 mmol/1), and
-1.0%/-1.2% (at 3.45/3.43 mmol/1); Boehringer
-0.4% (at 2.19 mmol/1), -0.7% (at 2.65 mmol/1), and
± 0.0% (at 3.32 mmol/1). The maximal allowable inac-
curacy of the individual internal quality control blocks
(9 measurements at the start and the end of the run; 3
measurements after each tenth patient sample) was cal-
culated from the maximal allowable bias (1.5%), the
mean CV obtained for that specific control serum and
the 95% confidence interval. As an example we cite the
Beckman arsenazo measurements with a mean CV of
0.7% (for all three control samples). The maximal allow-
able deviation from the target should then be 3.2% for
the triplicates and 2.0% for the 9-fold measurements.
The deviations for all individual internal quality control
runs were within these calculated limits. For Johnson &
Johnson, the measured value (global mean and indivi-
dual mean per internal quality control block) always lays
in the control range, but the deviation from our fixed
target value was higher than 1.5% or the value calcu-
lated as explained above. Considering the fact that John-
son & Johnson do not use a target value, they considered
the quality control results as representative for the sys-
tem. The mean CV (CV range) of the quality control
runs for each of the test systems were: 0.6% (0.2 to
0.9%) for Johnson & Johnson, 0.7% (0.2 to 1.1%) for
Beckman arsenazo, 0.4% (0.1 to 0.9%) for Beckman
ISE, and 0.5% (0 to 0.8%) for Boehringer. The recom-
mended within-day CV values were 1.5% for Johnson &
Johnson and 1% for the both Beckman and the Boeh-
ringer systems.
The mean deviations and between-day standard devia-
tions for the ion Chromatographie method were 0.2
±0.8% (CRM 303, 2.47 mmol/1) and 0.6 ±0.5%
(CRM 304, 2.20 mmol/1).
From these data, we conclude that all test systems were
under adequate control during the study.
Evaluation of routine method bias
The results of the method evaluations are presented
as bias plots (see fig. 1, each data point was calculated
from the mean of within-run triplicates) (note: linear
regression was not applied because of the narrow con-
centration range of the samples). The following outly-
ing samples (routine results differing more than 15%
from ion chromatography) were excluded from the
further calculations: samples 67 (—20.9%) and 75
(—18.2%) for Johnson & Johnson and sample 54
(—17.0%) for Boehringer. Further, 4 samples had to
be excluded because of internal quality control prob-
lems of ion chromatography in one run (repetition was
not possible because of limited sample volume). From
the data in figure 1, mean biases and 95% confidence
intervals were calculated: 0.0 ± 0.59% for Johnson &
Johnson, 1.3 ± 0.62% for Beckman arsenazo, —0.4
±0.44% for Beckman indirect ISE, and -1.9
± 0.42% for Boehringer. For the following interpreta-
tion, it should be noted that a bias in the order of
—0.6 to + 1.1% has to be taken into account for the
ion Chromatographie method itself (see internal quality
control data of the ion Chromatographie method). Ac-
cording to the most stringent model of Gowans et al.
(6), which is based on the biological variation of
serum total calcium, routine methods should have val-
ues for bias < 0.7%. However, since the bias of the
ion chromatography reference method already ex-
ceeded this limit, it was not possible to assess whether
the routine test systems fulfilled the specifications set
by Gowans. According to the model of Harris (7),
using the specification that routine method bias should
be < 1/8 of the reference range, a bias limit of 1.8%
would be calculated. Considering the possible bias of
—0.6 to + 1.1% of the ion Chromatographie method,
the limits for bias in this study would be —2.9% and
+ 2.4% for the Harris model. With the above calcu-
lated data for bias (including the 95% confidence in-
terval), it can be concluded that all four routine test
systems satisfy the latter criterion for bias. The low
values for the 95% confidence intervals of the biases
additionally indicate that the test systems were not
influenced by the common patient matrices.
Evaluation of routine method inaccuracy
Routine method inaccuracy was evaluated by calculation
of the deviation of single routine results from the mean
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Fig. l Bias plots of the routine test system results vs those ob- o-cresolphthalein (d) (Note: each data point was calculated from
tained by ion chromatography: Johnson & Johnson arsenazo(III) the mean of within-run triplicates),
(a), Beckman arsenazo(III) (b), Beckman ISE (c), and Boehringer
of triplicates obtained with the ion Chromatographie
method. These deviations are assessed against various
criteria for total error. Among them are the total error
criteria of 10% as applied in the German (8) and Ameri-
can (9) external quality assessment surveys, and the total
error criterion as expressed by Tonks (10), being 1/4 of
the reference range, resulting in a limit of 3.7%. How-
ever, those criteria have to be expanded in our case by
the inaccuracy of the ion Chromatographie method
which lies in the order of 1% (see above), resulting in
limits of 11 and 4.7% for the deviation of singlicates. It
should be noted further that these limits usually should
be satisfied in 95% of the measurements performed. De-
viations > 11% were observed for none of the test sys-
tems (except for outliers as already indicated), demon-
strating that all test systems are able to satisfy limits of
total error applied in external quality assessment. The
total error limit, according to the model of Tonks, was
exceeded in 6.4% of the samples for Johnson & John-
son, in 3.5% of the samples for Beckman arsenazo, in
3.6% of the samples for Beckman indirect ISE, and in
4.8% of the samples for Boehringer. Three of the sys-
tems tested also satisfied this more stringent limit, and
only the Johnson & Johnson test system exceeded the
limit in slightly more than 5% of the cases. It should be
noted here that the low values for total error stem from
the excellent within-run imprecision of the test systems.
The mean within-run CV (calculated from the tripli-
cates) was in the order of 0.5% for Johnson & Johnson,
Beckman ISE, and Boehringer. Only the Beckman
arsenazo method showed a slightly increased within-run
CV, namely 0.8%.
Conclusion
The study revealed that the intrinsic quality of com-
monly used test systems for serum total calcium satisfies
even some of the more stringent criteria for method bias
and inaccuracy. However, the study was undertaken un-
der within-run and rigorous internal quality control con-
ditions, and in the application laboratories of the respec-
tive manufacturers. The same quality of performance
cannot be expected in the routine laboratory. However,
a similar investigation in the routine laboratory would
need a different experimental design, e.g., larger
amounts of samples sent to at least 5 different laborato-
ries per test system, and treatment of the samples as
normal routine samples. We therefore conclude that rou-
tine measurements of serum total calcium are still a
challenge for the average routine laboratory. This is par-
ticularly true for appropriate installation of a test system
as well as the efforts that have to be investigated for
internal quality control. In particular, laboratories should
use stringent internal quality control criteria and control
materials with highly accurate target values, and should
take special care to reduce between-run variability.
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